Oncology Nursing News®

Skin Cancer/Melanoma

Patients Rely on Nurses for Crucial Immunotherapy Information

Patients Rely on Nurses for Crucial Immunotherapy Information

BY GRACE CHERRY, NP, MSN, RN

ctDNA Monitoring Is Important for BRAF-Mutant Melanoma

ctDNA Monitoring Is Important for BRAF-Mutant Melanoma

BY DANIELLE TERNYILA

Eliminating Gender-Based Barriers to Immunotherapy

Eliminating Gender-Based Barriers to Immunotherapy

BY KATIE KOSKO

A Note to Nurses on Skin Cancer Awareness Month

A Note to Nurses on Skin Cancer Awareness Month

BY BRIELLE BENYON

Survivors of Childhood Cancer Have Increased Skin Cancer Risk

Survivors of Childhood Cancer Have Increased Skin Cancer Risk

BY CAROLINE SEYMOUR

Melanoma Advances: Where We Are and Where We're Going

Melanoma Advances: Where We Are and Where We're Going

BY DOUGLAS B. JOHNSON, MD

Adverse Events of BRAF and MEK Inhibitors

Adverse Events of BRAF and MEK Inhibitors

BY MICHAEL A. POSTOW, MD

Risks Versus Benefits in Combining Immunotherapies

Risks Versus Benefits in Combining Immunotherapies

BY RYAN J. SULLIVAN, MD

FDA Approves Pembrolizumab for Adjuvant Treatment of Advanced Melanoma

FDA Approves Pembrolizumab for Adjuvant Treatment of Advanced Melanoma

BY BRIELLE BENYON

FDA Approves Pembrolizumab for Advanced Merkel Cell Carcinoma

FDA Approves Pembrolizumab for Advanced Merkel Cell Carcinoma

BY GINA COLUMBUS

External Resources

MJH Associates
American Journal of Managed Care
Cure
MD Magazine
Pharmacy Times
Physicians' Education Resource
Specialty Pharmacy Times
TargetedOnc

OncNurse Resources

Newsroom
Continuing Education
Discussions
Web Exclusives

About Us
Advertise
Advisory Board
Careers
Contact Us
Privacy Policy
Terms & Conditions

Intellisphere, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright OncNursing 2006-2019
Intellisphere, LLC. All Rights Reserved.